ArticleInternational journal of pharmaceutics: X2026
Self-assembly of sodium caprate in simulated intestinal fluids and with a therapeutic peptide: A small-angle neutron scattering study.
Article in International journal of pharmaceutics: X, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The self-assembly behavior of sodium caprate (C10), a widely used intestinal permeation enhancer, was characterized under intestinally relevant conditions using small-angle neutron scattering (SANS) with contrast variation. Systems containing 100 mM C10, alone and in fasted-state (FaSSIF) and fed-state (FeSSIF) simulated intestinal fluid, together with 300 mM C10 in the presence of the therapeutic peptide octreotide, were investigated at pH 6.5 and 8.5. At pH 6.5, C10 alone formed coexisting ellipsoidal aggregates, vesicles, and large droplets. Addition of FaSSIF promoted co-assembled mixed structures, including large ellipsoidal aggregates, vesicles, and bilayer-like morphologies, while FeSSIF shifted the system further toward bilayer discs. The most pronounced structural reorganization occurred in the presence of octreotide, where C10 aggregates transformed into large bilayer discs with aggregation numbers approaching 18,000. At pH 8.5, all systems converge to small spherical micelles (radius 15-20 Å), with the notable exception of the C10-octreotide system, which forms prolate rod-like micelles. Contrast-dependent fitting showed that octreotide promotes axial micellar elongation without substantially altering radial packing, indicating amphiphilic cosurfactant-like behavior rather than peptide incorporation into the hydrophobic core. Coarse-grained molecular dynamics simulations supported this interpretation, showing rod-like aggregate formation in the presence of octreotide and cosurfactant-like behavior, with hydrophobic residues inserted into the micelle and hydrophilic Lys and Thr residues positioned at the interface. These findings demonstrate that intestinal fluid composition and peptide-excipient interactions are principal determinants of C10 aggregate architecture, providing a foundation for the rational design of caprate- and fatty-acid-based absorption enhancer systems for oral peptide delivery. Author keywords sodium caprate, small-angle neutron scattering, contrast variation, intestinal fluid, octreotide, cosurfactant, permeation enhancer.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.